SCD and MTHFD2 inhibitors for high‐risk acute myeloid leukaemia patients, as suggested by ELN2017‐pathway association

Detalles Bibliográficos
Autores principales: Kim, Han Sun, Kim, Doyeon, Kim, Jiwoo, Park, Sunghyouk, de Guzman, Arvie Camille V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307990/
https://www.ncbi.nlm.nih.gov/pubmed/37381167
http://dx.doi.org/10.1002/ctm2.1311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307990/
https://www.ncbi.nlm.nih.gov/pubmed/37381167
http://dx.doi.org/10.1002/ctm2.1311

Ejemplares similares